Business · 20/03/2025Updated: 10/17/2026 · 1 min read
FDA Revokes Three COVID-19 Emergency Use Authorizations for In Vitro Diagnostic Tests
Summary
The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorizations (EUAs) for three COVID-19 diagnostic tests from Beckman Coulter, Inc., citing reasons for each revocation.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →